Effect of Probiotics on Psychiatric Symptoms and Central Nervous System Functions in Human Health and Disease: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Abstract
Background: The gut microbiota impacts on central nervous system (CNS) function via the microbiota–gut–brain axis. Thus, therapeutics targeting the gut microbiota such as probiotics have the potential for improving mental health. This meta-analysis synthesizes the evidence regarding the impacts of probiotics on psychological well-being, psychiatric symptoms and CNS functioning. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were applied for executing this review using the databases PubMed, Web of Science and Cochrane Library. The data were summarized at qualitative and quantitative level. Results: Fifty-four randomized placebo-controlled studies were included, of which 30 were eligible for meta-analysis. If investigated, the probiotics mostly exerted effects on CNS function. Most probiotics did not affect mood, stress, anxiety, depression and psychiatric distress when compared to placebo at the qualitative level. At quantitative level, depression and psychiatric distress improved slightly in the probiotic condition (depression: mean difference −0.37 (95% CI: −0.55, −0.20); p ≤ 0.0001; psychiatric distress: mean difference −0.33 (95% CI: −0.53, −0.13); p = 0.001). Conclusions: To date it is unclear to which extent and in which specific areas next generation probiotics selected and developed for their ability to improve psychiatric condition and potentially other CNS functions are promising.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Study outcomes at qualitative level for the studies included in the meta-analysis. Comparison between the probiotic and placebo group [20,30,32,33,37,38,41,42,44,45,46,47,48,49,51,52,55,57,58,63,64,66,67,68,69,70,71,72,77,78]. ↔: no significant differences between the groups; ↑: significant improvement in the probiotic group versus placebo p < 0.05; ↑↑: significant improvement in the probiotic group versus placebo p < 0.01.](https://figures.cochat.ai/paper-figures/010dae08d1eb4611a34ae3766efb58eb/effect-of-probiotics-on-psychiatric-symptoms-and-central-nervous-system-figure-3.jpg)
![Figure 4 Quantitative analysis for Profile of Mood States (POMS) of randomized controlled trials receiving either probiotics or placebo treatment. Murata 2018 [54], Ohsawa 2018 [58], Sashihara 2013 [69], Shinkai 2013 [72].](https://figures.cochat.ai/paper-figures/477f3d704f4445ec8196a11ccac6953a/effect-of-probiotics-on-psychiatric-symptoms-and-central-nervous-system-figure-4.jpg)
![Figure 5 Quantitative analysis for Perceived Stress scale (PSS) of randomized controlled trials receiving either probiotics or placebo treatment. Chung 2014 [36], Messaoudi 2011 [52], Östlund-Lagerström 2016 [59], Patterson 2020 [60], Sanchez 2017 [68].](https://figures.cochat.ai/paper-figures/2fe5d256818e44e8a10d6a24eb9dfd9f/effect-of-probiotics-on-psychiatric-symptoms-and-central-nervous-system-figure-5.jpg)
![Figure 6 Quantitative analysis for anxiety of randomized controlled trials receiving either probiotics or placebo treatment. Eskandarzadeh 2021 [30], Gualtieri 2020 [42], Ho 2021 [43], Karbownik 2020 [46], Kato-Kataoka 2016 [47], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Patterson 2020 [60], Raygan 2018 [62], Raygan 2019 [63], Roman 2018 [65], Sanchez 2017 [68], Steenbergen 2015 [73], Takada 2016 [74], Takada 2017 [75], Tran 2019 [76].](https://figures.cochat.ai/paper-figures/ee653936804f4076bc36fb0800d74ee3/effect-of-probiotics-on-psychiatric-symptoms-and-central-nervous-system-figure-6.jpg)
![Figure 7 Quantitative analysis for depression of randomized controlled trials receiving either probiotics or placebo treatment. Akkasheh 2016 [32], Ho 2021 [43], Kazemi 2019 [48], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Papalini 2019 [20], Raygan 2018 [62], Raygan 2019 [63], Reininghaus 2020 [64], Roman 2018 [65], Rudzki 2019 [67], Sanchez 2017 [68], Steenbergen 2015 [73], Zhang 2021 [79].](https://figures.cochat.ai/paper-figures/7128695be92747c89adc9226fa779d97/effect-of-probiotics-on-psychiatric-symptoms-and-central-nervous-system-figure-7.jpg)
![Figure 8 Overview of psychiatric distress symptom outcomes according to questionnaire. Gualtieri 2020 [42], Messaoudi 2011 [52], Mohammadi 2016 [53], Nishida 2019 [56], Nishihira 2014 [57], Raygan 2018 [62], Reininghaus2020 [64], Rudzki 2019 [67].](https://figures.cochat.ai/paper-figures/603661f9ea7a4c60825874d537431b31/effect-of-probiotics-on-psychiatric-symptoms-and-central-nervous-system-figure-8.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, it has been shown that a mixture of Lactobacillus and Bifidobacterium strains exerts some beneficial effects in healthy populations, as measured by different scales accounting for anxiety, stress, and psychopathological disorders [6,14].”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clinical studies indicate that combinations of Lactobacillus and Bifidobacterium strains can exert beneficial effects on stress, anxiety, and broader psychopathological outcomes in healthy populations, as assessed using validated psychological scales (de Le Morvan Sequeira et al., 2022; Messaoudi et al., 2011).”
From Psychobiotics in mental health: insights from human clinical trials via the gut-brain axis (2026) · cites this paper as de Le Morvan Sequeira et al., 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [6]
In the citing paper
“This observation is in line with recent meta-analyses conclusions identifying inconsistent effects of probiotics regarding pooled meta-analytic outcomes and denoting the need for further research to determine appropriate dosage, strains, and intervention duration between healthy and clinical samples [6,52,66].”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Mohammadi, A. A., Jazayeri, S., Khosravi-Darani, K., Solati, Z., Mohammadpour, N., Asemi, Z., Adab, Z., Djalali, M., Tehrani-Doost, M., Hosseini, M., et al. (2016) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000023 · Cited by 239 · cited 6×
“(2016), used combinations with capsules and yoghurts with and without probiotics [53].”
MethodResultInfluentialRetractedRaygan, F., Ostadmohammadi, V., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.07.017 · Cited by 84 · cited 13×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
BackgroundInfluentialRetractedMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“, studies only mentioned that no group differences existed without reporting the data) and/or (ii) the heterogeneity of the applied measurements was too high for a quantitative summary [27,28].”
BackgroundRoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787 · cited 1×
“The risk of bias was assessed using the Cochrane risk-of-bias tool for randomized trials (RoB 2) [31].”
MethodLiberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182 · cited 1×
“The former are important for the maintenance of the gut barrier function but also the overall health of the host [7,8].”
BackgroundIntroduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600 · cited 1×
“The GI microbiota is the total amount of living microorganisms colonizing the GI tract of a host organism [4].”
BackgroundUtilization of the PICO framework to improve searching PubMed for clinical questions
Schardt, C., Adams, M. B., Owens, T., Keitz, S., & Fontelo, P. (2007) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-7-16 · Cited by 3,053 · cited 1×
“, participants (P), interventions (I), comparators (C), outcome (O) and study design (S) [25] were applied to define the eligibility criteria.”
MethodDysbiosis of the gut microbiota in disease
Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26191 · Cited by 1,710 · cited 1×
“The former are important for the maintenance of the gut barrier function but also the overall health of the host [7,8].”
BackgroundThe gut microbiome in neurological disorders
Cryan, J. F., O'Riordan, K. J., Sandhu, K., Peterson, V., & Dinan, T. G. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30356-4 · Cited by 1,336 · cited 1×
“Since the gastrointestinal (GI) microbiota influences brain function and behavior, understanding the mechanisms could provide resources for improving psychological well-being in health and maybe even in psychiatric conditions [3].”
BackgroundMessaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.-F., Rougeot, C., Pichelin, M., Cazaubiel, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510004319 · Cited by 1,324 · cited 6×
“Kato-Kataoka 2016 [47], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Pat-”
InfluentialConsumption of fermented milk product with probiotic modulates brain activity
Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192 · cited 6×
“(2013) investigated the effects of a multi-strain probiotic using fMRI during identification of emotional face expressions and found that probiotic treatment affected brain activity of regions that control central processing of emotion and sensation [21].”
BackgroundResultInfluentialNext-generation probiotics: the spectrum from probiotics to live biotherapeutics
O’Toole, P. W., Marchesi, J. R., & Hill, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.57 · Cited by 971 · cited 1×
“These probiotics are derived from next generation sequencing and are selected for specific properties and specific indication [82].”
BackgroundThe Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Pinto-Sanchez, M. I., Hall, G. B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J. T., Martin, F.-P., Cominetti, O., Welsh, C., Rieder, A., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.003 · Cited by 821
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767 · cited 11×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
InfluentialSteenbergen, L., Sellaro, R., van Hemert, S., Bosch, J. A., & Colzato, L. S. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.04.003 · Cited by 671 · cited 3×
“…groups: PL (93), PRlowdose (92), PRhighdose (93) Lactobacillus pentosus strain b240 (1); low-dose: 2 × 109 CFU, high dose: 2 × 1010 CFU; 1/day; tablets Behavioral: POMS↔, SF-36 ↓ Steenbergen et al. (2015) [73] NLD Sad Mood 4 40 (NR); f: 80%; age: PL→19.7 (1.7), PR→20.2 (2.4); healthy; groups: PL…”
InfluentialClarke, D. M., & Currie, K. C. (2009) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02471.x · Cited by 661
Rao, A. V., Bested, A. C., Beaulne, T. M., Katzman, M. A., Iorio, C., Berardi, J. M., & Logan, A. C. (2009) · Gut Pathogens · doi:10.1186/1757-4749-1-6 · Cited by 577 · cited 4×
“(2009) [61] CAN Chronic Fatigue Syndrome 8 39 (35); f: 77.”
BackgroundInfluentialImpact of consuming a milk drink containing a probiotic on mood and cognition
Benton, D., Williams, C., & Brown, A. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602546 · Cited by 554 · cited 4×
“(2007) [35] UK Mood and Cognition 3 132 (126); f: 59.”
BackgroundResultInfluentialKazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H., & Djafarian, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.010 · Cited by 534 · cited 12×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
BackgroundResultInfluentialAllen, A. P., Hutch, W., Borre, Y. E., Kennedy, P. J., Temko, A., Boylan, G., Murphy, E., Cryan, J. F., Dinan, T. G., & Clarke, G. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.191 · Cited by 513 · cited 14×
“(2016) [34] IRL Stress 8 27 (22); f: 0%; age: 25.”
BackgroundInfluentialRudzki, L., Ostrowska, L., Pawlak, D., Małus, A., Pawlak, K., Waszkiewicz, N., & Szulc, A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.010 · Cited by 499 · cited 14×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
InfluentialHealth, T. L. G. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30432-0 · Cited by 417
Kelly, J. R., Allen, A. P., Temko, A., Hutch, W., Kennedy, P. J., Farid, N., Murphy, E., Boylan, G., Bienenstock, J., Cryan, J. F., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.11.018 · Cited by 355 · cited 16×
“(2017) [49] IRL Stress and Cognitive Performance 8 29 (NR); f: 0%; age: 24.”
BackgroundInfluentialEffect of probiotics on central nervous system functions in animals and humans: a systematic review
Wang, H., Lee, I.-S., Braun, C., & Enck, P. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm16018 · Cited by 334 · cited 2×
“Thus, it is logical, why therapeutics targeting the GI microbiota, such as prebiotics, probiotics and postbiotics/paraprobiotics (inactivated bacteria or fractions) [12,13] and fermented milks [14], are of potential interest for (i) influencing mood and stress resilience in health and disease and, (ii) adjunct treatme…”
BackgroundSelf-citationBrain-Gut-Microbiota Axis and Mental Health
Dinan, T. G., & Cryan, J. F. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000519 · Cited by 325 · cited 1×
“65); healthy; ConditionA (17): highCFU[50billion] + high species count [18], ConditionB (19): highCFU[50billion] + low species count [10], ConditionC (16): control/placebo group, ConditionD (19): lowCFU[15billion] + high species count[18], ConditionE (19): lowCFU[10billion] + low species count [10] commercially availa…”
BackgroundRomijn, A. R., Rucklidge, J. J., Kuijer, R. G., & Frampton, C. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416686694 · Cited by 323 · cited 3×
“(2017) [66] NZL Depression 8 79 (79); f: 78.”
InfluentialKato-Kataoka, A., Nishida, K., Takada, M., Kawai, M., Kikuchi-Hayakawa, H., Suda, K., Ishikawa, H., Gondo, Y., Shimizu, K., Matsuki, T., et al. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.04134-15 · Cited by 288 · cited 3×
“Kato-Kataoka 2016 [47], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Pat-”
InfluentialNishida, K., Sawada, D., Kuwano, Y., Tanaka, H., & Rokutan, K. (2019) · Nutrients · doi:10.3390/nu11081859 · Cited by 276 · cited 20×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
BackgroundInfluentialLew, L.-C., Hor, Y.-Y., Yusoff, N. A. A., Choi, S.-B., Yusoff, M. S. B., Roslan, N. S., Ahmad, A., Mohammad, J. A. M., Abdullah, M. F. I. L., Zakaria, N., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.09.010 · Cited by 272 · cited 9×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
InfluentialHwang, Y.-H., Park, S., Paik, J.-W., Chae, S.-W., Kim, D.-H., Jeong, D.-G., Ha, E., Kim, M., Hong, G., Park, S.-H., et al. (2019) · Nutrients · doi:10.3390/nu11020305 · Cited by 254 · cited 10×
“(2019) [44] KOR Mild Cognitive Impairment 12 100 (100); f: 66%; age: PL→69.”
BackgroundInfluentialTakada, M., Nishida, K., Kataoka‐Kato, A., Gondo, Y., Ishikawa, H., Suda, K., Kawai, M., Hoshi, R., Watanabe, O., Igarashi, T., et al. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12804 · Cited by 243 · cited 1×
“…PL→19.7 (1.7), PR→20.2 (2.4); healthy; groups: PL (20), PR (20) Ecologic Barrier (8); 2.5 × 109 CFU/g; 1/day; powder Behavioral: LEIDS-r total ↓↓↓: aggression ↓↓; rumination ↓↓↓; BDI II↔; BAI↔ Takada et al. (2016) [74] JAP Stress 8 149 (140); f: 45.7%; age: PL→22.8 ± 0.2, PR→23.0 ± 0.2; healthy;…”
InfluentialProbiotics drive gut microbiome triggering emotional brain signatures
Bagga, D., Reichert, J. L., Koschutnig, K., Aigner, C. S., Holzer, P., Koskinen, K., Moissl-Eichinger, C., & Schöpf, V. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1460015 · Cited by 226 · cited 15×
“Three studies compared the results of the probiotic groups with the results of a placebo group and also with the results of a no interventional group [18,19,21].”
BackgroundResultInfluentialChudzik, A., Orzyłowska, A., Rola, R., & Stanisz, G. J. (2021) · Biomolecules · doi:10.3390/biom11071000 · Cited by 209 · cited 1×
“However, not all pre-clinical studies report superiority of probiotics over placebo, the literature being reviewed elsewhere [9,15,16].”
BackgroundXiao, J., Katsumata, N., Bernier, F., Ohno, K., Yamauchi, Y., Odamaki, T., Yoshikawa, K., Ito, K., & Kaneko, T. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200488 · Cited by 203 · cited 2×
“(2020) [77] JAP Memory 16 80 (80); f: 51.”
BackgroundInfluentialKobayashi, Y., Kuhara, T., Oki, M., & Xiao, J.-Z. (2019) · Beneficial Microbes · doi:10.3920/bm2018.0170 · Cited by 195 · cited 3×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Kazemi et al. (2019) [48] IRN Depression 8 110 (110); f: 70.9%; age: 36.47 (8.03); mild to moderate major depression; groups: PL…”
InfluentialChung, Y.-C., Jin, H.-M., Cui, Y., Kim, D. S., Jung, J. M., Park, J.-I., Jung, E.-S., Choi, E.-K., & Chae, S.-W. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.07.007 · Cited by 173 · cited 4×
“Four studies compared the placebo group with several probiotic groups with different CFU concentration [36,54,72,76], while two studies compared them with different species [46,48].”
ResultInfluentialRajoka, M. S. R., Thirumdas, R., Mehwish, H. M., Umair, M., Khurshid, M., Hayat, H. F., Phimolsiripol, Y., Pallarés, N., Martí-Quijal, F. J., & Barba, F. J. (2021) · Antioxidants · doi:10.3390/antiox10101563 · Cited by 173 · cited 1×
“Besides probiotics, there are also other potential GI microbiota-modulating substances [17].”
BackgroundDickerson, F. B., Stallings, C., Origoni, A., Katsafanas, E., Savage, C. L. G., Schweinfurth, L. A. B., Goga, J., Khushalani, S., & Yolken, R. H. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13m01579 · Cited by 166 · cited 4×
“…intervention, 3 weeks wash-out, 3 weeks other intervention Biocult Strong, HOMEOSYN (9); each 1.5 × 1010 CFU/3 g; 1/day; powder Behavioral: SCL90R:↔; BUT ↓ (S) Dickerson et al. (2014) [38] USA Schizophrenia 14 65 (65); f: 35.4%; age: PL→48.1 (9.4), PR→44.4 (11.0); diagnosed schizophrenia with…”
InfluentialClinical and metabolic response to vitamin D plus probiotic in schizophrenia patients
Ghaderi, A., Banafshe, H. R., Mirhosseini, N., Moradi, M., Karimi, M.-A., Mehrzad, F., Bahmani, F., & Asemi, Z. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2059-x · Cited by 166 · cited 3×
“(2019) [41] IRN Schizophrenia 12 60 (60); f: 6.”
InfluentialSeverance, E. G., Gressitt, K. L., Stallings, C. R., Katsafanas, E., Schweinfurth, L. A., Savage, C. L. G., Adamos, M. B., Sweeney, K. M., Origoni, A. E., Khushalani, S., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.11.019 · Cited by 165 · cited 3×
“(2017) [71] USA Schizophrenia 14 65 (56); f: 33.”
InfluentialDiop, L., Guillou, S., & Durand, H. (2008) · Nutrition Research · doi:10.1016/j.nutres.2007.10.001 · Cited by 162 · cited 10×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
InfluentialTakada, M., Nishida, K., Gondo, Y., Kikuchi-Hayakawa, H., Ishikawa, H., Suda, K., Kawai, M., Hoshi, R., Kuwano, Y., Miyazaki, K., et al. (2017) · Beneficial Microbes · doi:10.3920/bm2016.0150 · Cited by 160 · cited 13×
“gen 2015 [73], Takada 2016 [74], Takada 2017 [75], Tran 2019 [76].”
BackgroundInfluentialWang, H., Braun, C., Murphy, E. F., & Enck, P. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000203 · Cited by 159 · cited 3×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Tran et al. (2019) [76] USA Anxiety 4(28 days) 90 (68); f: 75.6%; age: 20.59 (2.65); healthy; ConditionA (17): highCFU[50billion]…”
MethodInfluentialSelf-citationNishida, K., Sawada, D., Kawai, T., Kuwano, Y., Fujiwara, S., & Rokutan, K. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13594 · Cited by 158 · cited 3×
“The reason for this is that six studies used different questionnaires for the same outcome [30,49,55,56,60,70].”
ResultInfluentialPROVIT: Supplementary Probiotic Treatment and Vitamin B7 in Depression—A Randomized Controlled Trial
Reininghaus, E. Z., Platzer, M., Kohlhammer-Dohr, A., Hamm, C., Mörkl, S., Bengesser, S. A., Fellendorf, F. T., Lahousen-Luxenberger, T., Leitner-Afschar, B., Schöggl, H., et al. (2020) · Nutrients · doi:10.3390/nu12113422 · Cited by 157 · cited 6×
“6%) [41,62,64], selective serotonin reuptake inhibitors (SSRI) (n = 2; 3.”
BackgroundInfluentialSanchez, M., Darimont, C., Panahi, S., Drapeau, V., Marette, A., Taylor, V., Doré, J., & Tremblay, A. (2017) · Nutrients · doi:10.3390/nu9030284 · Cited by 138 · cited 7×
“…PL (39), PR (40); with SSRI treatment Sanprobi IBS (1); 10 × 109 CFU; 2/day; capsule Behavioral: HAM-D 17↔, SCL-90↔, PSS-10↔ Neuropsychological: APT ↑↑, Stroop Test A + B↔, RFFT↔, TMT A + B↔, CVLT ↑ Sanchez et al. (2017) [68] CAN Depression, Anxiety and Stress 24 126 (125); f: 61.6%; age:…”
InfluentialDickerson, F., Adamos, M., Katsafanas, E., Khushalani, S., Origoni, A., Savage, C., Schweinfurth, L., Stallings, C., Sweeney, K., Goga, J., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12652 · Cited by 137 · cited 15×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
BackgroundInfluentialZhang, X., Chen, S., Zhang, M., Ren, F., Ren, Y., Li, Y., Liu, N., Zhang, Y., Zhang, Q., & Wang, R. (2021) · Nutrients · doi:10.3390/nu13072238 · Cited by 136 · cited 3×
“(2021) [79] CHN Depression 9 82 (69); f: 63.”
ResultInfluentialHo, Y.-T., Tsai, Y.-C., Kuo, T. B. J., & Yang, C. C. H. (2021) · Nutrients · doi:10.3390/nu13082820 · Cited by 130 · cited 16×
“Eskandarzadeh 2021 [30], Gualtieri 2020 [42], Ho 2021 [43], Karbownik 2020 [46],”
BackgroundInfluentialPotential Health-Promoting Benefits of Paraprobiotics, Inactivated Probiotic Cells
Akter, S., Park, J.-H., & Jung, H. K. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1911.11019 · Cited by 127 · cited 1×
“Thus, it is logical, why therapeutics targeting the GI microbiota, such as prebiotics, probiotics and postbiotics/paraprobiotics (inactivated bacteria or fractions) [12,13] and fermented milks [14], are of potential interest for (i) influencing mood and stress resilience in health and disease and, (ii) adjunct treatme…”
BackgroundAGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders
Preidis, G. A., Weizman, A. V., Kashyap, P. C., & Morgan, R. L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.060 · Cited by 127 · cited 2×
“As a consequence of this, clinical trials usually do not match all standards imposed by the US Food and Drug Administration (FDA) or European Medical Agency (EMA) [80].”
BackgroundTrends in Probiotic(s)-Fermented milks and their in vivo functionality: A review
Sakandar, H. A., & Zhang, H. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.01.054 · Cited by 125 · cited 1×
“Thus, it is logical, why therapeutics targeting the GI microbiota, such as prebiotics, probiotics and postbiotics/paraprobiotics (inactivated bacteria or fractions) [12,13] and fermented milks [14], are of potential interest for (i) influencing mood and stress resilience in health and disease and, (ii) adjunct treatme…”
BackgroundReis, D. J., Ilardi, S. S., & Punt, S. E. W. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199041 · Cited by 123 · cited 1×
“However, not all pre-clinical studies report superiority of probiotics over placebo, the literature being reviewed elsewhere [9,15,16].”
BackgroundStress matters: randomized controlled trial on the effect of probiotics on neurocognition
Papalini, S., Michels, F., Kohn, N., Wegman, J., van Hemert, S., Roelofs, K., Arias-Vasquez, A., & Aarts, E. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.100141 · Cited by 123 · cited 4×
“…f: PR→57%, PL→65.6%; age: PR→72.6 (5.8), PL→72 (5.6); mentally and physically fit; groups: PL (124), PR (125) Lactobacillus reuteri DSM 17938 (1); 1 × 108 CFU; 2/day; powder Behavioral: HADS↔,PSS↔ Papalini et al. (2019) [20] NLD Neurocognition 4(28 days) 61 (58); f: 100%; age: PL→22 (SEM:…”
BackgroundInfluentialRoman, P., Estévez, A. F., Miras, A., Sánchez-Labraca, N., Cañadas, F., Vivas, A. B., & Cardona, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-29388-5 · Cited by 116 · cited 5×
“In addition, studies also included participants with mild cognitive impairment [44], bipolar I/schizoaffective disorder in a manic episode [39], general anxiety disorder [30], chronic fatigue syndrome [61], chronic primary insomnia [43] and fibromyalgia [65].”
BackgroundInfluentialYamamura, S., Morishima, H., Kumano‐go, T., Suganuma, N., Matsumoto, H., Adachi, H., Shigedo, Y., Mikami, A., Kai, T., Masuyama, A., et al. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602898 · Cited by 115 · cited 5×
“(2009) [78] JAP Sleep 3 30 (29); f: 20.”
BackgroundInfluentialRaygan, F., Ostadmohammadi, V., Bahmani, F., & Asemi, Z. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.02.007 · Cited by 112 · cited 6×
“6%) [41,62,64], selective serotonin reuptake inhibitors (SSRI) (n = 2; 3.”
InfluentialInoue, T., Kobayashi, Y., Mori, N., Sakagawa, M., Xiao, J.-Z., Moritani, T., Sakane, N., & Nagai, N. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0193 · Cited by 112 · cited 2×
“(2018) [45] JAP Cognitive Function 12 39 (38); f: 64.”
InfluentialCaso, J. R., MacDowell, K. S., González-Pinto, A., García, S., de Diego-Adeliño, J., Carceller-Sindreu, M., Sarramea, F., Caballero-Villarraso, J., Gracia-García, P., De la Cámara, C., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01755-3 · Cited by 107 · cited 2×
“Interestingly, the composition of the gut microbiota is different in patients with severe and moderate major depression disorder in comparison to healthy individuals [5].”
BackgroundTran, N., Zhebrak, M., Yacoub, C., Pelletier, J., & Hawley, D. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.043 · Cited by 104 · cited 14×
“gen 2015 [73], Takada 2016 [74], Takada 2017 [75], Tran 2019 [76].”
BackgroundResultInfluentialOhsawa, K., Nakamura, F., Uchida, N., Mizuno, S., & Yokogoshi, H. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2017.1365824 · Cited by 101 · cited 3×
“(2018) [58] JAP Cognitive Function 8 61 (60); f: 56.”
InfluentialBagga, D., Aigner, C. S., Reichert, J. L., Cecchetto, C., Fischmeister, F. P. S., Holzer, P., Moissl-Eichinger, C., & Schöpf, V. (2019) · European Journal of Nutrition · doi:10.1007/s00394-018-1732-z · Cited by 94 · cited 14×
“…(Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Bagga et al. (2019) [18] AUT Functional connectivity in brain 4 45 (NR); f: 51.1%; age: 26.24 (4.76); healthy; groups: PL (15), PR (15), CN…”
BackgroundResultInfluentialShinkai, S., Toba, M., Saito, T., Sato, I., Tsubouchi, M., Taira, K., Kakumoto, K., Inamatsu, T., Yoshida, H., Fujiwara, Y., et al. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512003753 · Cited by 92 · cited 14×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
ResultInfluentialMurata, M., Kondo, J., Iwabuchi, N., Takahashi, S., Yamauchi, K., Abe, F., & Miura, K. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0197 · Cited by 92 · cited 4×
“Four studies compared the placebo group with several probiotic groups with different CFU concentration [36,54,72,76], while two studies compared them with different species [46,48].”
ResultInfluentialEskandarzadeh, S., Effatpanah, M., Khosravi-Darani, K., Askari, R., Hosseini, A. F., Reisian, M., & Jazayeri, S. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1598669 · Cited by 80 · cited 8×
“(2021) [30] IRN Generalized Anxiety Disorder 8 48 (39); f: 81.”
BackgroundMethodInfluentialGualtieri, P., Marchetti, M., Cioccoloni, G., LORENZO, A. D., Romano, L., Cammarano, A., Colica, C., Condò, R., & Renzo, L. D. (2020) · Mediators of Inflammation · doi:10.1155/2020/2346126 · Cited by 73 · cited 4×
“(2020) [42] ITA Anxiety 12 142 (97); f: 61.”
BackgroundInfluentialSawada, D., Kawai, T., Nishida, K., Kuwano, Y., Fujiwara, S., & Rokutan, K. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.01.042 · Cited by 72 · cited 9×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
InfluentialRajoka, M. S. R., Mehwish, H. M., Kitazawa, H., Barba, F. J., Berthelot, L., Umair, M., Zhu, Q., He, Z., & Zhao, L. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.131954 · Cited by 72 · cited 1×
“Furthermore, the immune-modulating potential of the GI microbiota [5] and some probiotics has been reported [6].”
BackgroundMazurak, N., Broelz, E., Storr, M., & Enck, P. (2015) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15071 · Cited by 71 · cited 1×
“Furthermore, not all probiotics can be expected to be of similar efficacy (number of strains, type of strain(s)) [81], and they may not be effective across”
BackgroundSelf-citationÖstlund-Lagerström, L., Kihlgren, A., Repsilber, D., Björkstén, B., Brummer, R. J., & Schoultz, I. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0198-1 · Cited by 69 · cited 5×
“Kato-Kataoka 2016 [47], Messaoudi 2011 [52], Nishida 2019 [56], Östlund-Lagerström 2016 [59], Pat-”
InfluentialPatterson, E., Griffin, S. M., Ibarra, A., Ellsiepen, E., & Hellhammer, D. H. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100277 · Cited by 67 · cited 5×
“…BDI↔, LEIDS-r↔, BIS-BAS↔ Neuropsychological: SECPT↔; Digit Span Test↔, Emotional face-matching paradigm↔, Emotional face-word stroop paradigm↔, Classic colour-word stroop paradigm↔ Neurophysiological: fMRI↔ Patterson et al. (2020) [60] DEU Stress,Anxiety 5 120 (117); f: 49.6%; age:…”
InfluentialDe Lorenzo, A., Costacurta, M., Merra, G., Gualtieri, P., Cioccoloni, G., Marchetti, M., Varvaras, D., Docimo, R., & Di Renzo, L. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1236-2 · Cited by 62 · cited 3×
“(2017) [37] ITA Psychological Profile 3 48 (48); f: 100%; age: NWL30.”
Nishihira, J., Kagami-Katsuyama, H., Tanaka, A., Nishimura, M., Kobayashi, T., & Kawasaki, Y. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.09.002 · Cited by 53 · cited 3×
“(2014) [57] JAP Stress 12 238 (224); f: 69.”
BackgroundInfluentialde Sequeira, C. L. M., Kaeber, M., Cekin, S., Enck, P., & Mack, I. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163497 · Cited by 51 · cited 3×
“What is more, in the field of probiotic research in the GI-related disciplines, effects of probiotics on psyche were not thoroughly investigated in the past and, if reported, no effects were observed [26].”
BackgroundInfluentialSelf-citationSashihara, T., Nagata, M., Mori, T., Ikegami, S., Gotoh, M., Okubo, K., Uchida, M., & Itoh, H. (2013) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0490 · Cited by 46 · cited 9×
“3724 (1); 3.24 × 108 CFU/day; 2/day; capsules Behavioral: BDI ↓, STAI↔, PSS↔ Sashihara et al. (2013) [69] JAP MentalCondition 4 44 (44); f: 0%; age: PL→20.2 ± 1.1, PR+αLA→19.9 ± 0.9, PR→19.8 ± 0.9; engaged in high-intensity training ≥ 5 days/week; groups: PL (14), PR (15), PR+αLA (15) Lactobacillus…”
InfluentialMack, I., Schwille‐Kiuntke, J., Mazurak, N., Niesler, B., Zimmermann, K., Mönnikes, H., & Enck, P. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.06.028 · Cited by 45
Self-citationAdikari, A. M. G. C. P., Appukutty, M., & Kuan, G. (2020) · Nutrients · doi:10.3390/nu12071920 · Cited by 41 · cited 13×
“Author (Year) Country Subject IntakeLength (Week) SampleSize (A); Sex (f%); AgeMean (SD); HealthCondition; Groups (N) Probiotic Species (N); Dose; Times Intake per Day; Application Outcomes Diop et al. (2008) [40] FRA Stress 3 75 (75); f: 72%; age: 38 ± 11; healthy;groups: PL (37), PR (38) Probio stick (2); 3 × 109 CF…”
BackgroundInfluentialKarbownik, M. S., Kręczyńska, J., Kwarta, P., Cybula, M., Wiktorowska-Owczarek, A., Kowalczyk, E., Pietras, T., & Szemraj, J. (2020) · Nutrients · doi:10.3390/nu12051469 · Cited by 26 · cited 4×
“(2020) [46] POL Stress 4 92 (92); f: 60%; age: 22.”
ResultInfluentialMeta-analysis: formulating, evaluating, combining, and reporting
Normand, S.-L. T. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990215)18:3<321::aid-sim28>3.0.co;2-p · cited 1×
“, studies only mentioned that no group differences existed without reporting the data) and/or (ii) the heterogeneity of the applied measurements was too high for a quantitative summary [27,28].”
Background
Research works printed but not linked: 1
- (Review Manager (RevMan), 2020). Review Manager (RevMan), Version 5.4.
Cited by
A comprehensive review of probiotics and human health-current prospective and applications
Sarita, B., Samadhan, D., Hassan, M. Z., & Kovaleva, E. G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1487641 · Cited by 250
The role of probiotics and prebiotics in modulating of the gut-brain axis
Ansari, F., Neshat, M., Pourjafar, H., Jafari, S. M., Samakkhah, S. A., & Mirzakhani, E. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1173660 · Cited by 200
Sasso, J. M., Ammar, R. M., Tenchov, R., Lemmel, S., Kelber, O., Grieswelle, M., & Zhou, Q. A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00127 · Cited by 204
Merkouris, E., Mavroudi, T., Miliotas, D., Tsiptsios, D., Serdari, A., Christidi, F., Doskas, T. K., Mueller, C., & Tsamakis, K. (2024) · Microorganisms · doi:10.3390/microorganisms12020411 · Cited by 109
“…not affect mood, stress, anxiety, depression, and psychiatric distress when compared to placebo at the qualitative level, indicating that there is not yet strong enough evidence to support the inclusion of probiotic, prebiotic and symbiotic supplements in treatment guidelines for depression [37].”
ResultNg, Q. X., Lim, Y. L., Yaow, C. Y. L., Ng, W., Thumboo, J., & Liew, T. M. (2023) · Nutrients · doi:10.3390/nu15061351 · Cited by 107
Metadata
- Authors
- Le Morvan de Sequeira, C., Hengstberger, C., Enck, P., & Mack, I.
- Affiliations
- Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, 72076 Tübingen, Germany
- Universitätsklinikum Tübingen (DE)
- Corresponding author
- Mack, Isabelle
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2022-01-30
- Volume
- 14
- Issue
- 3
- Pages
- 621
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC8839125
- OpenAlex
- W4210634251
- Cited by
- 82
- References
- 82
- Citations by year
- 2026: 15 · 2025: 18 · 2024: 18 · 2023: 20 · 2022: 10
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- German Aerospace Center (50WB1920)
- Open Access Publishing Fund of Tübingen University (not applicable)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- probiotics, gut microbiota, microbiota-gut-brain axis, psychiatric symptoms, depression, anxiety, stress, psychiatric distress, mood, central nervous system function, mental health
- MeSH terms
- Gastrointestinal Microbiome, Anxiety Disorders, Central Nervous System, Depression, Humans, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.